Bioanalytical Automation of Samples

Update: 2021-07-30

Description

In this podcast interview, Jason Evans (Scientist at Q² Solutions) discusses the importance of automation and key advantages of taking an assay from the bench to an automated platform. He also explains the increase in throughput when his lab transitioned to automated assays and the hurdles he faced when automating assays.

Comments

In Channel

What is the Role of Digital Pathology in Clinical Trials

2023-11-1729:00

AI in Pathology: Advancements, Challenges, and the Road Ahead

2023-06-3028:41

Flow Cytometry as an IVD technology for Companion Diagnostics

2022-11-3020:35

Flexible Approaches for Biotech Companies in Clinical Trials

2022-06-2223:21

Risk Management for Biotech Companies in Clinical Trials

2022-05-1621:15

3 Things to Consider in Preparation for Your Biotech Testing or Trial

2022-04-0725:06

Hybrid assays: an interview with Barry Jones and Adriane Spytko

2022-03-1711:14

Managing Sample Data from Vendors

2021-09-1517:33

Automation within an ADME Laboratory

2021-08-2608:15

Bioanalytical Automation of Samples

2021-07-3011:18

Consent Tracking for Clinical Samples

2021-07-2818:12

Tracking Clinical Trial Samples

2021-07-2814:23

Avoiding Canceled Tests in Pediatric Samples

2021-02-0219:59

Covid Vaccine Testing

2020-09-1518:56

Hybrid Assays for Protein Bioanalysis

2020-07-2924:21

High Throughput ADME Testing

2020-07-2920:33

Liquid Biopsy Collection in Clinical Development Programs

2020-07-2922:37

An Next Generation Sequencing Approach to Influenza Vaccine Development

2019-10-2524:00

Standardization of Tumor Mutational Burden by Alignment to Reference Standards

2019-10-2528:22

Monitoring the Tumor Micro-environment with Flow Cytometry - Mark Edinger

2019-03-0520:22

00:00

1.0x

Bioanalytical Automation of Samples

#box-pro-ellipsis-176313840215827{-webkit-line-clamp:2;}Bioanalytical Automation of Samples

Bioanalytical Automation of Samples

Q Squared Solutions

Bioanalytical Automation of Samples